Urovalve Announces Start of Patient Enrollment for Pilot Study of Its Surinate(R) Urinary Catheter

NEWARK, N.J.--(BUSINESS WIRE)--Urovalve, a medical device company focused on creating products for urinary flow and control, announced today the initiation of patient enrollment for a pilot study of its Surinate® Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, an inability to empty the bladder caused by obstruction of the urethra.
MORE ON THIS TOPIC